- Titulinis
- Visos kategorijos
- Emerging Technologies for Heart Diseases
![Emerging Technologies for Heart Diseases - Humanitas](https://www.humanitas.lt/uploads/_CGSmartImage/no-cover-2f803130014a29326b57c421f6b58da5.png)
Emerging Technologies for Heart Diseases
Balsavo 0
ISBN: 9780128137048
Leidimo metai: 2020
Leidėjas: Academic Press
Leidinio kalba: Anglų
Formatas: Kieti viršeliai
Formatas: 10.875×8.5
Leidimo metai: 2020
Leidėjas: Academic Press
Leidinio kalba: Anglų
Formatas: Kieti viršeliai
Formatas: 10.875×8.5
Kaina:
Šių parametrų produkto neturime
Likutis pakankamas
Pristatymo terminas Lietuvoje 3-6 savaitės
Pristatymo terminas Lietuvoje 1-4 darbo dienos. Galimas nedidelis vėlavimas
Pristatymo terminas Lietuvoje 3-6 savaitės
Pristatymo sąlygos
Aprašymas
The increasing pace of advances in cardiology throughout the last few decades has fundamentally altered the natural course of heart patients. In the last few years, available therapies have been revolutionized completely by new transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Also, molecular biology and genetics have a rapidly growing impact on cardiovascular diseases, enabling the field of regenerative medicine to become increasingly closer to routine clinical implementation. <p><i><b>Emerging Technologies for Heart Diseases</b></i> was conceived to cover the recent extensive literature on current and novel therapeutic options for cardiac patients. The first volume is dedicated to heart failure and valvular disorders, and the second covers myocardial ischemia and arrhythmias. The clinical topic is addressed in several chapters divided according to the therapeutic approach (mechanical or electrical device-based, or cell and gene-based). Each of the 46 chapters focuses on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations that have not yet been tested in a preclinical model. Also, the book discusses future challenges and opportunities for clinical implementation. Lessons learned from abandoned experimental practices are also covered, giving the readers the widest possible perspective of current therapeutic dilemmas.</p> <p>Overall, this textbook was designed for physicians who want to stay up-to-date with current therapies and those of the future, for biomedical companies, and for those who wish to broaden their knowledge of new cardiovascular therapeutic options.</p> <b><i></i></b>
Atsiliepimai (0)
Palikite atsiliepimą